Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

Tae Woo Kim, Jin Hyup Lee, Chien Fu Hung, Shiwen Peng, Richard Roden, Mei Cheng Wang, Raphael Viscidi, Ya Chea Tsai, Liangmei He, Pei Jer Chen, David A K Boyd, T. C. Wu

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Severe acute respiratory syndrome (SARS) is a serious threat to public health and the economy on a global scale. The SARS coronavirus (SARS-CoV) has been identified as the etiological agent for SARS. Thus, vaccination against SARS-CoV may represent an effective approach to controlling SARS. DNA vaccines are an attractive approach for SARS vaccine development, as they offer many advantages over conventional vaccines, including stability, simplicity, and safety. Our investigators have previously shown that DNA vaccination with antigen linked to calreticulin (CRT) dramatically enhances major histocompatibility complex class I presentation of linked antigen to CD8 + T cells. In this study, we have employed this CRT-based enhancement strategy to create effective DNA vaccines using SARS-CoV nucleocapsid (N) protein as a target antigen. Vaccination with naked CRT/N DNA generated the most potent N-specific humoral and T-cell-mediated immune responses in vaccinated C57BL/6 mice among all of the DNA constructs tested. Furthermore, mice vaccinated with CRT/N DNA were capable of significantly reducing the titer of challenging vaccinia virus expressing the N protein of the SARS virus. These results show that a DNA vaccine encoding CRT linked to a SARS-CoV antigen is capable of generating strong N-specific humoral and cellular immunity and may potentially be useful for control of infection with SARS-CoV.

Original languageEnglish
Pages (from-to)4638-4645
Number of pages8
JournalJournal of Virology
Volume78
Issue number9
DOIs
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

Nucleocapsid Proteins
Severe Acute Respiratory Syndrome
Coronavirus
DNA Vaccines
Calreticulin
Vaccination
DNA
Antigens
Vaccine Potency
CD8 Antigens
T-Lymphocytes
Vaccinia virus
Antigen Presentation
Humoral Immunity
Infection Control
Major Histocompatibility Complex
Inbred C57BL Mouse
Cellular Immunity
Vaccines
Public Health

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)
  • Virology

Cite this

Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus. / Kim, Tae Woo; Lee, Jin Hyup; Hung, Chien Fu; Peng, Shiwen; Roden, Richard; Wang, Mei Cheng; Viscidi, Raphael; Tsai, Ya Chea; He, Liangmei; Chen, Pei Jer; Boyd, David A K; Wu, T. C.

In: Journal of Virology, Vol. 78, No. 9, 2004, p. 4638-4645.

Research output: Contribution to journalArticle

Kim, TW, Lee, JH, Hung, CF, Peng, S, Roden, R, Wang, MC, Viscidi, R, Tsai, YC, He, L, Chen, PJ, Boyd, DAK & Wu, TC 2004, 'Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus', Journal of Virology, vol. 78, no. 9, pp. 4638-4645. https://doi.org/10.1128/JVI.78.9.4638-4645.2004
Kim, Tae Woo ; Lee, Jin Hyup ; Hung, Chien Fu ; Peng, Shiwen ; Roden, Richard ; Wang, Mei Cheng ; Viscidi, Raphael ; Tsai, Ya Chea ; He, Liangmei ; Chen, Pei Jer ; Boyd, David A K ; Wu, T. C. / Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus. In: Journal of Virology. 2004 ; Vol. 78, No. 9. pp. 4638-4645.
@article{6db57db8fb1c485591741130ef3cc5ae,
title = "Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus",
abstract = "Severe acute respiratory syndrome (SARS) is a serious threat to public health and the economy on a global scale. The SARS coronavirus (SARS-CoV) has been identified as the etiological agent for SARS. Thus, vaccination against SARS-CoV may represent an effective approach to controlling SARS. DNA vaccines are an attractive approach for SARS vaccine development, as they offer many advantages over conventional vaccines, including stability, simplicity, and safety. Our investigators have previously shown that DNA vaccination with antigen linked to calreticulin (CRT) dramatically enhances major histocompatibility complex class I presentation of linked antigen to CD8 + T cells. In this study, we have employed this CRT-based enhancement strategy to create effective DNA vaccines using SARS-CoV nucleocapsid (N) protein as a target antigen. Vaccination with naked CRT/N DNA generated the most potent N-specific humoral and T-cell-mediated immune responses in vaccinated C57BL/6 mice among all of the DNA constructs tested. Furthermore, mice vaccinated with CRT/N DNA were capable of significantly reducing the titer of challenging vaccinia virus expressing the N protein of the SARS virus. These results show that a DNA vaccine encoding CRT linked to a SARS-CoV antigen is capable of generating strong N-specific humoral and cellular immunity and may potentially be useful for control of infection with SARS-CoV.",
author = "Kim, {Tae Woo} and Lee, {Jin Hyup} and Hung, {Chien Fu} and Shiwen Peng and Richard Roden and Wang, {Mei Cheng} and Raphael Viscidi and Tsai, {Ya Chea} and Liangmei He and Chen, {Pei Jer} and Boyd, {David A K} and Wu, {T. C.}",
year = "2004",
doi = "10.1128/JVI.78.9.4638-4645.2004",
language = "English",
volume = "78",
pages = "4638--4645",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus

AU - Kim, Tae Woo

AU - Lee, Jin Hyup

AU - Hung, Chien Fu

AU - Peng, Shiwen

AU - Roden, Richard

AU - Wang, Mei Cheng

AU - Viscidi, Raphael

AU - Tsai, Ya Chea

AU - He, Liangmei

AU - Chen, Pei Jer

AU - Boyd, David A K

AU - Wu, T. C.

PY - 2004

Y1 - 2004

N2 - Severe acute respiratory syndrome (SARS) is a serious threat to public health and the economy on a global scale. The SARS coronavirus (SARS-CoV) has been identified as the etiological agent for SARS. Thus, vaccination against SARS-CoV may represent an effective approach to controlling SARS. DNA vaccines are an attractive approach for SARS vaccine development, as they offer many advantages over conventional vaccines, including stability, simplicity, and safety. Our investigators have previously shown that DNA vaccination with antigen linked to calreticulin (CRT) dramatically enhances major histocompatibility complex class I presentation of linked antigen to CD8 + T cells. In this study, we have employed this CRT-based enhancement strategy to create effective DNA vaccines using SARS-CoV nucleocapsid (N) protein as a target antigen. Vaccination with naked CRT/N DNA generated the most potent N-specific humoral and T-cell-mediated immune responses in vaccinated C57BL/6 mice among all of the DNA constructs tested. Furthermore, mice vaccinated with CRT/N DNA were capable of significantly reducing the titer of challenging vaccinia virus expressing the N protein of the SARS virus. These results show that a DNA vaccine encoding CRT linked to a SARS-CoV antigen is capable of generating strong N-specific humoral and cellular immunity and may potentially be useful for control of infection with SARS-CoV.

AB - Severe acute respiratory syndrome (SARS) is a serious threat to public health and the economy on a global scale. The SARS coronavirus (SARS-CoV) has been identified as the etiological agent for SARS. Thus, vaccination against SARS-CoV may represent an effective approach to controlling SARS. DNA vaccines are an attractive approach for SARS vaccine development, as they offer many advantages over conventional vaccines, including stability, simplicity, and safety. Our investigators have previously shown that DNA vaccination with antigen linked to calreticulin (CRT) dramatically enhances major histocompatibility complex class I presentation of linked antigen to CD8 + T cells. In this study, we have employed this CRT-based enhancement strategy to create effective DNA vaccines using SARS-CoV nucleocapsid (N) protein as a target antigen. Vaccination with naked CRT/N DNA generated the most potent N-specific humoral and T-cell-mediated immune responses in vaccinated C57BL/6 mice among all of the DNA constructs tested. Furthermore, mice vaccinated with CRT/N DNA were capable of significantly reducing the titer of challenging vaccinia virus expressing the N protein of the SARS virus. These results show that a DNA vaccine encoding CRT linked to a SARS-CoV antigen is capable of generating strong N-specific humoral and cellular immunity and may potentially be useful for control of infection with SARS-CoV.

UR - http://www.scopus.com/inward/record.url?scp=84984586321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984586321&partnerID=8YFLogxK

U2 - 10.1128/JVI.78.9.4638-4645.2004

DO - 10.1128/JVI.78.9.4638-4645.2004

M3 - Article

C2 - 15078946

AN - SCOPUS:84984586321

VL - 78

SP - 4638

EP - 4645

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 9

ER -